CARGO Therapeutics, Inc. Common Stock
CRGX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $8 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $1 | $1 | $1 | $2 |
| Gross Profit | -$1 | -$1 | -$1 | -$2 |
| % Margin | – | – | -17.4% | – |
| R&D Expenses | $8 | $31 | $40 | $36 |
| G&A Expenses | $8 | $12 | $11 | $11 |
| SG&A Expenses | $8 | $12 | $11 | $11 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $37 | $46 | -$1 | $0 |
| Operating Expenses | $53 | $88 | $49 | $47 |
| Operating Income | -$53 | -$88 | -$50 | -$47 |
| % Margin | – | – | -640.3% | – |
| Other Income/Exp. Net | $3 | $4 | $5 | $5 |
| Pre-Tax Income | -$50 | -$84 | -$45 | -$42 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$50 | -$84 | -$45 | -$42 |
| % Margin | – | – | -580.3% | – |
| EPS | -1.04 | -1.77 | -0.99 | -0.88 |
| % Growth | 41.2% | -78.8% | -12.5% | – |
| EPS Diluted | -1.04 | -1.77 | -0.99 | -0.88 |
| Weighted Avg Shares Out | 48 | 48 | 46 | 48 |
| Weighted Avg Shares Out Dil | 48 | 48 | 46 | 48 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $4 | $5 | $5 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $2 |
| EBITDA | -$15 | -$41 | -$44 | -$40 |
| % Margin | – | – | -562.9% | – |